Figure 2From: PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib PTEN expression. PTEN negative (IRS 0-3, a); Weak Positive (IRS 4-6, b); Positive (IRS 7-9, c); and Strong Positive (IRS 10-12, d).Back to article page